Rumford, Megan http://orcid.org/0000-0001-7480-9273
Lythgoe, Mark
McNeish, Iain http://orcid.org/0000-0002-9387-7586
Gabra, Hani http://orcid.org/0000-0002-3322-4399
Tookman, Laura
Rahman, Nazneen
George, Angela
Krell, Jonathan
Funding for this research was provided by:
The Royal Marsden and The Institute of Cancer Research and Imperial College Biomedical Research Centres grant A165.
Article History
Received: 21 May 2019
Accepted: 7 February 2020
First Online: 25 February 2020
Competing interests
: Summary of competing financial and non-financial interests: M.R. was employed by AstraZeneca throughout the duration of this project. H.G. has received honoraria from AstraZeneca, was employed at Imperial College at the time that this work was undertaken but now works for AstraZeneca whilst also still holding a position of employment at Imperial College. A.G. has received honoraria paid to departmental research account from AstraZeneca, Roche and Tesaro. I.M. has received honoraria from Clovis Oncology, Tesaro, AstraZeneca and Takeda, and has also received grants from AstraZeneca, outside the submitted work. J.K. has received honoraria from Clovis Oncology, Tesaro and AstraZeneca, outside the submitted work. N.R. is a non-executive director of AstraZeneca. L.T. has received Tesaro and AstraZeneca, outside the submitted work. M.L. has no disclosures. None of the aforementioned companies had any input into the study design, data collection, reporting or preparation of the manuscript.